Kevin Mullin (D-CA) sits on the House Committee on Energy and Commerce, which has jurisdiction over the Pharmaceuticals & Biotech sector. Pharmaceuticals & Biotech represents 15.1% of his identifiable donations ($0.39M), ranking him third among House Democrats in donor concentration from this sector.
FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 1, 2026 · internal signal score 71/100.